|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.88 HKD | -5.76% |
|
-8.13% | -9.16% |
| 03-06 | Macquarie Downgrades Prada to Neutral from Outperform, Price Target is HK$46 | MT |
| 03-06 | Italy - Factors to watch on March 6 | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.25 | 4.94 | 6.77 | 8.85 | 9.89 | |||||
Return on Total Capital | 1.42 | 5.72 | 8.03 | 10.48 | 11.68 | |||||
Return On Equity % | -1.86 | 9.87 | 14.15 | 18.25 | 20.33 | |||||
Return on Common Equity | -1.87 | 9.9 | 14.1 | 18.29 | 20.33 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 71.96 | 75.69 | 78.85 | 80.44 | 79.84 | |||||
SG&A Margin | 62.12 | 56.42 | 57.09 | 54.8 | 53.39 | |||||
EBITDA Margin % | 13.38 | 21.13 | 22.89 | 26.68 | 27.88 | |||||
EBITA Margin % | 6.26 | 16.35 | 18.84 | 22.71 | 23.73 | |||||
EBIT Margin % | 5.62 | 15.84 | 18.48 | 22.45 | 23.54 | |||||
Income From Continuing Operations Margin % | -2.24 | 8.77 | 11.17 | 14.25 | 15.53 | |||||
Net Income Margin % | -2.23 | 8.74 | 11.07 | 14.2 | 15.44 | |||||
Net Avail. For Common Margin % | -2.23 | 8.74 | 11.07 | 14.2 | 15.44 | |||||
Normalized Net Income Margin | 1.66 | 8.61 | 10.48 | 12.8 | 13.6 | |||||
Levered Free Cash Flow Margin | 24.44 | 28.66 | 21.8 | 7.26 | 20.56 | |||||
Unlevered Free Cash Flow Margin | 25.8 | 29.52 | 22.5 | 8.28 | 21.59 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.36 | 0.5 | 0.59 | 0.63 | 0.67 | |||||
Fixed Assets Turnover | 0.64 | 0.95 | 1.18 | 1.24 | 1.26 | |||||
Receivables Turnover (Average Receivables) | 7.97 | 10.86 | 12.7 | 12.82 | 13.11 | |||||
Inventory Turnover (Average Inventory) | 0.99 | 1.24 | 1.25 | 1.2 | 1.33 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.35 | 1.53 | 1.63 | 1.49 | 1.52 | |||||
Quick Ratio | 0.71 | 0.99 | 1.01 | 0.82 | 0.89 | |||||
Operating Cash Flow to Current Liabilities | 0.48 | 0.81 | 0.75 | 0.8 | 0.98 | |||||
Days Sales Outstanding (Average Receivables) | 45.92 | 33.61 | 28.74 | 28.46 | 27.93 | |||||
Days Outstanding Inventory (Average Inventory) | 368.41 | 293.2 | 292.28 | 304.63 | 275.64 | |||||
Average Days Payable Outstanding | 179.14 | 152.31 | 146.53 | 164.78 | 145.24 | |||||
Cash Conversion Cycle (Average Days) | 235.19 | 174.5 | 174.49 | 168.32 | 158.32 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 101.28 | 89.2 | 76.2 | 67.16 | 63.07 | |||||
Total Debt / Total Capital | 50.32 | 47.15 | 43.25 | 40.18 | 38.68 | |||||
LT Debt/Equity | 76.48 | 67.76 | 60.3 | 52.57 | 48.92 | |||||
Long-Term Debt / Total Capital | 38 | 35.81 | 34.22 | 31.45 | 30 | |||||
Total Liabilities / Total Assets | 56.32 | 55.04 | 52.55 | 49.09 | 48.31 | |||||
EBIT / Interest Expense | 2.57 | 11.59 | 16.48 | 13.7 | 14.3 | |||||
EBITDA / Interest Expense | 14.52 | 24.72 | 30 | 22.04 | 22.01 | |||||
(EBITDA - Capex) / Interest Expense | 12.45 | 19.95 | 24.87 | 12.23 | 16.87 | |||||
Total Debt / EBITDA | 3.76 | 2.45 | 1.89 | 1.53 | 1.42 | |||||
Net Debt / EBITDA | 3.18 | 1.58 | 1.12 | 1.12 | 0.9 | |||||
Total Debt / (EBITDA - Capex) | 4.39 | 3.04 | 2.28 | 2.75 | 1.85 | |||||
Net Debt / (EBITDA - Capex) | 3.7 | 1.96 | 1.35 | 2.02 | 1.18 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -24.89 | 38.92 | 24.81 | 12.52 | 14.92 | |||||
Gross Profit, 1 Yr. Growth % | -24.84 | 46.12 | 30.02 | 14.78 | 14.07 | |||||
EBITDA, 1 Yr. Growth % | -38.75 | 109.3 | 39.84 | 19.36 | 17.2 | |||||
EBITA, 1 Yr. Growth % | -50.59 | 304.22 | 61.63 | 26.95 | 21.47 | |||||
EBIT, 1 Yr. Growth % | -55.66 | 291.78 | 58.54 | 25.49 | 20.51 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -121.1 | -642.79 | 58.98 | 43.53 | 25.25 | |||||
Net Income, 1 Yr. Growth % | -121.17 | -643.52 | 58.09 | 44.25 | 25.02 | |||||
Normalized Net Income, 1 Yr. Growth % | -72.21 | 620.48 | 67.65 | 25.05 | 22.1 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -121.16 | -643.53 | 58.09 | 44.25 | 25.02 | |||||
Accounts Receivable, 1 Yr. Growth % | -8.56 | 13.49 | 0.72 | 22.06 | 4.59 | |||||
Inventory, 1 Yr. Growth % | -6.94 | -0.58 | 14.76 | 2.96 | 10.62 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -11.11 | -1.1 | 1.92 | 13.06 | 11.75 | |||||
Total Assets, 1 Yr. Growth % | -7.25 | 6.6 | 6.01 | 3.22 | 12.28 | |||||
Tangible Book Value, 1 Yr. Growth % | -5.83 | 14.25 | 16.63 | 12.89 | 17.41 | |||||
Common Equity, 1 Yr. Growth % | -4.55 | 9.95 | 11.83 | 10.67 | 14.16 | |||||
Cash From Operations, 1 Yr. Growth % | -26.85 | 93.03 | -1.73 | 2.81 | 42.96 | |||||
Capital Expenditures, 1 Yr. Growth % | -64.77 | 100.47 | 9.96 | 214.57 | -39.5 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 40.31 | 62.92 | -1.44 | -64.24 | 225.65 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 36.21 | 58.9 | -1.32 | -60.41 | 199.66 | |||||
Dividend Per Share, 1 Yr. Growth % | - | 100 | 57.14 | 24.55 | 19.71 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -12.19 | 2.15 | 31.68 | 18.5 | 13.71 | |||||
Gross Profit, 2 Yr. CAGR % | -12.22 | 4.79 | 37.83 | 22.17 | 14.43 | |||||
EBITDA, 2 Yr. CAGR % | -22.79 | 15.92 | 68.21 | 35.41 | 19.72 | |||||
EBITA, 2 Yr. CAGR % | -31.58 | 33.88 | 141.13 | 48.05 | 23.47 | |||||
EBIT, 2 Yr. CAGR % | -35.18 | 31.8 | 138.82 | 47.2 | 22.98 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -48.9 | 7.01 | 193.76 | 51.06 | 34.08 | |||||
Net Income, 2 Yr. CAGR % | -48.67 | 7.26 | 193.13 | 51.01 | 34.29 | |||||
Normalized Net Income, 2 Yr. CAGR % | -53.53 | 41.51 | 230.81 | 51.74 | 23.57 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -48.67 | 7.26 | 193.14 | 51.01 | 34.29 | |||||
Accounts Receivable, 2 Yr. CAGR % | -5.02 | 1.87 | 6.91 | 10.88 | 12.99 | |||||
Inventory, 2 Yr. CAGR % | 2.34 | -3.81 | 7.4 | 8.7 | 6.72 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 50.24 | -6.24 | 0.4 | 7.35 | 12.4 | |||||
Total Assets, 2 Yr. CAGR % | 18.12 | -0.57 | 6.31 | 4.61 | 7.65 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.06 | 3.73 | 15.43 | 14.74 | 15.13 | |||||
Common Equity, 2 Yr. CAGR % | -0.8 | 2.44 | 10.89 | 11.25 | 12.4 | |||||
Cash From Operations, 2 Yr. CAGR % | 27.38 | 18.83 | 37.72 | 0.51 | 21.24 | |||||
Capital Expenditures, 2 Yr. CAGR % | -37.69 | -15.96 | 48.47 | 85.98 | 37.95 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 212.56 | 51.19 | 24.37 | -39.25 | 7.91 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 200.85 | 47.12 | 22.96 | -36.09 | 8.91 | |||||
Dividend Per Share, 2 Yr. CAGR % | -23.62 | - | 77.28 | 39.9 | 22.1 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -6.78 | 2.32 | 9.2 | 24.95 | 17.3 | |||||
Gross Profit, 3 Yr. CAGR % | -7.68 | 4.03 | 12.61 | 29.68 | 19.41 | |||||
EBITDA, 3 Yr. CAGR % | -16.75 | 9.36 | 22.02 | 54.81 | 30.1 | |||||
EBITA, 3 Yr. CAGR % | -23.94 | 19.3 | 37.12 | 99.04 | 38.07 | |||||
EBIT, 3 Yr. CAGR % | -26.64 | 18.07 | 36.24 | 98.28 | 37.71 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -38.86 | 12.33 | 22.1 | 131.37 | 41.91 | |||||
Net Income, 3 Yr. CAGR % | -38.91 | 12.72 | 22.06 | 131.42 | 41.8 | |||||
Normalized Net Income, 3 Yr. CAGR % | -42.43 | 15.88 | 44.89 | 146.78 | 41.13 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -38.91 | 12.72 | 22.06 | 131.43 | 41.8 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.05 | 0.78 | 1.49 | 11.74 | 8.74 | |||||
Inventory, 3 Yr. CAGR % | 4.97 | 1.36 | 2.39 | 5.9 | 9.34 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 32.72 | 30.69 | -3.6 | 4.45 | 8.79 | |||||
Total Assets, 3 Yr. CAGR % | 11.26 | 14.15 | 1.58 | 5.27 | 7.1 | |||||
Tangible Book Value, 3 Yr. CAGR % | 1.31 | 5.28 | 7.86 | 14.58 | 15.63 | |||||
Common Equity, 3 Yr. CAGR % | -0.15 | 2.66 | 5.48 | 10.81 | 12.21 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.74 | 46.31 | 11.53 | 24.94 | 13.04 | |||||
Capital Expenditures, 3 Yr. CAGR % | -22.13 | -8.01 | -8.08 | 90.69 | 27.91 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | - | 151.55 | 29.47 | -16.64 | 6.32 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | 143.19 | 27.23 | -14.46 | 6.97 | |||||
Dividend Per Share, 3 Yr. CAGR % | -24.65 | 5.27 | - | 57.6 | 32.82 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | - | - | 7.03 | 8.51 | 10.98 | |||||
Gross Profit, 5 Yr. CAGR % | - | - | 8.38 | 10.94 | 13.33 | |||||
EBITDA, 5 Yr. CAGR % | - | - | 11.35 | 18.31 | 23.4 | |||||
EBITA, 5 Yr. CAGR % | - | - | 18.08 | 27.07 | 33.24 | |||||
EBIT, 5 Yr. CAGR % | - | - | 17.63 | 26.78 | 33.02 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | 14.55 | 26.46 | 26.76 | |||||
Net Income, 5 Yr. CAGR % | - | - | 14.39 | 26.71 | 26.81 | |||||
Normalized Net Income, 5 Yr. CAGR % | - | - | 15.86 | 26.55 | 38.52 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | 14.39 | 26.71 | 26.81 | |||||
Accounts Receivable, 5 Yr. CAGR % | - | - | 2.74 | 4.71 | 5.94 | |||||
Inventory, 5 Yr. CAGR % | - | - | 5.94 | 4.46 | 4.1 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | 18.7 | 20.8 | 2.51 | |||||
Total Assets, 5 Yr. CAGR % | - | - | 9.25 | 10.23 | 3.97 | |||||
Tangible Book Value, 5 Yr. CAGR % | - | - | 6.74 | 8.97 | 10.71 | |||||
Common Equity, 5 Yr. CAGR % | - | - | 4.13 | 6.01 | 8.2 | |||||
Cash From Operations, 5 Yr. CAGR % | - | - | 18.2 | 25.91 | 15.32 | |||||
Capital Expenditures, 5 Yr. CAGR % | - | - | 0.81 | 21.91 | 8.13 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 41.43 | 21.49 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | 41.46 | 20.63 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | 6.1 | 17.95 | - |
- Stock Market
- Equities
- 1913 Stock
- Financials Prada S.p.A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















